Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.